skip to main content
Language:
Search Limited to: Search Limited to: Resource type Show Results with: Show Results with: Search type Index

Tofacitinib in Amyopathic Dermatomyositis–Associated Interstitial Lung Disease

The New England journal of medicine, 2019-07, Vol.381 (3), p.291-293 [Peer Reviewed Journal]

Copyright © 2019 Massachusetts Medical Society. All rights reserved. ;ISSN: 0028-4793 ;EISSN: 1533-4406 ;DOI: 10.1056/NEJMc1900045 ;PMID: 31314977

Full text available

Citations Cited by
  • Title:
    Tofacitinib in Amyopathic Dermatomyositis–Associated Interstitial Lung Disease
  • Author: Chen, Zhiwei ; Wang, Xiaodong ; Ye, Shuang
  • Subjects: Autoimmune diseases ; Dermatomyositis ; Glucocorticoids ; Kinases ; Lung diseases ; Melanoma
  • Is Part Of: The New England journal of medicine, 2019-07, Vol.381 (3), p.291-293
  • Description: The autoimmune disease amyopathic dermatomyositis–associated interstitial lung disease, which is related to anti–melanoma differentiation–associated protein 5 antibodies, is often rapidly progressive. Patients who received glucocorticoids and tofacitinib had improved survival.
  • Publisher: United States: Massachusetts Medical Society
  • Language: English
  • Identifier: ISSN: 0028-4793
    EISSN: 1533-4406
    DOI: 10.1056/NEJMc1900045
    PMID: 31314977
  • Source: ProQuest One Psychology
    AUTh Library subscriptions: ProQuest Central

Searching Remote Databases, Please Wait